A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Effective treatment of neuropathic foot pain in diabetic patients is very important to
improve their quality of life. There are many medications used to reduce the diabetic
neuropathic pain, including anticonvulsants, anti-depressants or analgesics, but none is
universally satisfied. A few previous studies employing BOTOX® i.d. injection for control of
trigeminal neuralgia, post-herpes neuralgia indicate that BOTOX® was effective in controlling
neuropathic pain. Intradermal injection of BOTOX® to the dorsum of the foot in diabetics
should be effective in controlling diabetes-associated polyneuropathic pain of the foot.
Phase:
N/A
Details
Lead Sponsor:
Taipei Medical University Hospital
Collaborator:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA